Vanda Pharmaceuticals (VNDA) Change in Cash (2010 - 2026)
Vanda Pharmaceuticals recorded quarterly Change in Cash of -$30.8 million in Q1 2026, down 307.82% quarter-over-quarter from $14.8 million in Q4 2025, and down 425.07% year-over-year from $9.5 million in Q1 2025.
Vanda Pharmaceuticals' Change in Cash history runs 17 years deep, the most recent figure standing at -$30.8 million for Q1 2026.
- In Q1 2026, Change in Cash fell 425.07% year-over-year to -$30.8 million; the TTM figure through Mar 2026 stood at -$57.8 million (down 332.29% YoY), while the FY2025 annual figure was -$17.5 million, up 47.87% from the prior year.
- Change in Cash came in at -$30.8 million for Q1 2026 at Vanda Pharmaceuticals, down from $14.8 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $219.1 million in Q1 2023 to a low of -$204.1 million in Q2 2023.
- A 5-year average of $112529.4 and a median of -$8.7 million in 2022 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash soared 5428.21% in 2022 and slumped 2245.63% in 2023, its largest moves.
- Vanda Pharmaceuticals' Change in Cash stood at $85.6 million in 2022, then sank by 155.31% to -$47.4 million in 2023, then surged by 103.84% to $1.8 million in 2024, then surged by 715.23% to $14.8 million in 2025, then plunged by 307.82% to -$30.8 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$30.8 million, $14.8 million, and -$11.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -30.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.82 Mn |
| Dec 31, 2025 | 14.83 Mn |
| Sep 30, 2025 | -10.96 Mn |
| Jun 30, 2025 | -30.81 Mn |
| Mar 31, 2025 | 9.48 Mn |
| Dec 31, 2024 | 1.82 Mn |
| Sep 30, 2024 | -2.46 Mn |
| Jun 30, 2024 | -22.21 Mn |
| Mar 31, 2024 | -10.66 Mn |
| Dec 31, 2023 | -47.37 Mn |
| Sep 30, 2023 | 33.16 Mn |
| Jun 30, 2023 | -204.14 Mn |
| Mar 31, 2023 | 219.14 Mn |
| Dec 31, 2022 | 85.63 Mn |
| Sep 30, 2022 | -8.88 Mn |
| Jun 30, 2022 | -8.70 Mn |
| Mar 31, 2022 | 14.86 Mn |
| Dec 31, 2021 | 1.55 Mn |
| Sep 30, 2021 | -6.78 Mn |
| Jun 30, 2021 | -14.89 Mn |
| Mar 31, 2021 | 11.10 Mn |
| Dec 31, 2020 | 4.06 Mn |
| Sep 30, 2020 | -38.33 Mn |
| Jun 30, 2020 | 30.36 Mn |
| Mar 31, 2020 | 19.88 Mn |
| Dec 31, 2019 | 5.70 Mn |
| Sep 30, 2019 | -7.34 Mn |
| Jun 30, 2019 | 12.17 Mn |
| Mar 31, 2019 | -26.63 Mn |
| Dec 31, 2018 | 227,000.00 |
| Sep 30, 2018 | -113,000.00 |
| Jun 30, 2018 | -94.40 Mn |
| Mar 31, 2018 | 121.70 Mn |
| Dec 31, 2017 | 10.92 Mn |
| Sep 30, 2017 | 8.35 Mn |
| Jun 30, 2017 | -5.88 Mn |
| Mar 31, 2017 | -20.32 Mn |
| Dec 31, 2016 | 7.71 Mn |
| Sep 30, 2016 | 9.57 Mn |
| Jun 30, 2016 | -15.55 Mn |
| Mar 31, 2016 | -12.10 Mn |
| Dec 31, 2015 | 4.06 Mn |
| Sep 30, 2015 | -1.55 Mn |
| Jun 30, 2015 | 15.53 Mn |
| Mar 31, 2015 | -28.09 Mn |
| Dec 31, 2014 | 45.59 Mn |
| Sep 30, 2014 | -1.69 Mn |
| Jun 30, 2014 | -26.27 Mn |
| Mar 31, 2014 | -21.50 Mn |
| Dec 31, 2013 | -77.41 Mn |
| Sep 30, 2013 | 38.54 Mn |
| Jun 30, 2013 | -6.30 Mn |
| Mar 31, 2013 | 21.16 Mn |
| Dec 31, 2012 | -15.74 Mn |
| Sep 30, 2012 | 10.13 Mn |
| Jun 30, 2012 | -13.71 Mn |
| Mar 31, 2012 | 20.17 Mn |
| Dec 31, 2011 | 27.60 Mn |
| Sep 30, 2011 | 9.94 Mn |
| Jun 30, 2011 | -2.13 Mn |
| Mar 31, 2011 | 9.96 Mn |
| Dec 31, 2010 | -59.91 Mn |
| Sep 30, 2010 | -43.18 Mn |